- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Carcinoid Tumor
Total 38253 results
-
University of WashingtonMinnesota Ovarian Cancer AllianceTerminatedStage III Ovarian Cancer AJCC v8 | Stage IIIA Ovarian Cancer AJCC v8 | Stage IIIA1 Ovarian Cancer AJCC v8 | Stage IIIA2 Ovarian Cancer AJCC v8 | Stage IIIB Ovarian Cancer AJCC v8 | Stage IIIC Ovarian Cancer AJCC v8 | Stage IV Ovarian Cancer AJCC v8 | Stage IVA Ovarian Cancer AJCC v8 | Stage IVB Ovarian... and other conditionsUnited States
-
M.D. Anderson Cancer CenterUnknownKidney Cancer | Colorectal Cancer | Bladder Cancer | Skin Cancer | Endometrial Cancer | Uterus CancerUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedFollicular Lymphoma | B Cell Lymphoma | Non-Hodgkin's Lymphoma | Burkitt Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | B-cell Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Diffuse Well-differentiated Lymphocytic Lymphoma | B-Cell Diffuse LymphomaUnited States
-
University of RochesterUniversity of ArizonaCompletedFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | Burkitt's LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Immunoblastic Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular... and other conditionsUnited States
-
University of UtahRecruitingStage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Endometrial Clear Cell Adenocarcinoma | Endometrial Endometrioid Adenocarcinoma | Endometrial Serous Adenocarcinoma | Uterine Corpus Sarcoma | Uterine Corpus Carcinosarcoma | Stage IA Uterine Corpus Cancer | Stage IB Uterine Corpus CancerUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingSarcoma | Cervical Cancer | Ovarian Cancer | Fallopian Tube Cancer | Vulvar Cancer | Endometrial Cancer | Vaginal Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2) | Uterine LeiomyomataUnited States
-
Rutgers, The State University of New JerseyUniversity of California, Los Angeles; University of New MexicoActive, not recruitingKidney Cancer | Small Intestine Cancer | Lung Cancer | Prostate Cancer | Bladder Cancer | Colon Cancer | Thyroid Cancer | Rectum Cancer | Soft Tissue CancerUnited States
-
National Cancer Institute (NCI)WithdrawnAdvanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Recurrent Extrahepatic Bile Duct Cancer | Unresectable Extrahepatic Bile Duct Cancer | Stage II Gallbladder Cancer | Stage IIIA Gallbladder Cancer | Stage IIIB Gallbladder... and other conditions
-
University of California, San FranciscoNational Cancer Institute (NCI)UnknownLymphoma | Kidney Cancer | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Medical College of WisconsinRecruitingFollicular Lymphoma | Multiple Myeloma | Burkitt Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Lymphoma, Small Lymphocytic | Diffuse Large B Cell Lymphoma | Central Nervous System Lymphoma | Lymphomas Non-Hodgkin's B-CellUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Adult Lymphoblastic Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | Recurrent... and other conditionsUnited States
-
Beth ChristianGenentech, Inc.; CelgeneActive, not recruitingRecurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Burkitt Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Burkitt Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Recurrent High Grade B-Cell Lymphoma | Recurrent Aggressive Non-Hodgkin Lymphoma | Recurrent Burkitt Lymphoma | Recurrent Transformed B-Cell Non-Hodgkin LymphomaUnited States
-
Regenstrief Institute, Inc.Merck Sharp & Dohme LLC; Indiana UniversityCompletedCervical Cancer | Oropharyngeal Cancer | Genital Warts | Human Papilloma Virus Infection Type 11 | Human Papilloma Virus Infection Type 16 | Human Papilloma Virus Infection Type 18 | Human Papilloma Virus Infection Type 6
-
Apollo Therapeutics LtdNot yet recruitingColorectal Cancer | Pancreatic Adenocarcinoma | Ovarian Cancer | Prostate Cancer | Gastric Adenocarcinoma | Cholangiocarcinoma | Triple Negative Breast Cancer | Endometrial Adenocarcinoma | Appendiceal Adenocarcinoma
-
Huazhong University of Science and TechnologyRecruitingBladder Cancer | Non-Muscle-Invasive Bladder CancerChina
-
Janssen Research & Development, LLCRecruitingNon-Muscle Invasive Bladder NeoplasmsKorea, Republic of, United States, United Kingdom, China, Japan, Brazil, Argentina
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Shanghai Xianxiang Medical Technology Co., Ltd.RecruitingNon-Muscle-Invasive Bladder Cancer (NMIBC)China
-
RenJi HospitalBeiGene; RemeGen Co., Ltd.RecruitingHER2 | Non-Muscle Invasive Bladder CancerChina
-
White River Junction Veterans Affairs Medical CenterMedical University of South Carolina; National Cancer Institute (NCI); University...RecruitingNon-muscle-invasive Bladder CancerUnited States
-
Al-Azhar UniversityRecruiting
-
Universitaire Ziekenhuizen KU LeuvenUZ Leuven, Leuven, Belgium; Policlinico Universitario A. Gemelli, IRCSS, Rome... and other collaboratorsRecruitingCervical Cancer | Ovarian Neoplasms | Ovarian Cancer | Metastatic Cancer | Pelvic Cancer | Endometrial Cancer | Ovarian Carcinoma | Uterus Cancer | Sarcoma UterusBelgium, Czechia, Italy, Sweden
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Recruiting
-
VA Office of Research and DevelopmentUniversity of California, DavisRecruiting
-
CHU de Quebec-Universite LavalCanadian Institutes of Health Research (CIHR)RecruitingNon-Muscle Invasive Bladder CancerCanada
-
Carey Anders, M.D.Seagen Inc.RecruitingAdvanced Breast Cancer | Brain Metastases | Human Epidermal Growth Factor 2 Positive Carcinoma of BreastUnited States
-
Sir Mortimer B. Davis - Jewish General HospitalNot yet recruitingEndometrial Cancer | Uterine Neoplasm | Serous Adenocarcinoma
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingBiochemically Recurrent Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingRecurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Who Have Failed at Least Two Prior Lines of TherapyChina
-
National Cancer Institute (NCI)RecruitingStage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Locally Advanced Pancreatic Adenocarcinoma | Locally Advanced Unresectable Pancreatic Adenocarcinoma | Unresectable Pancreatic AdenocarcinomaUnited States
-
West China HospitalRecruitingRecurrence | Stomach Neoplasms | Siewert Type II Adenocarcinoma of Esophagogastric Junction | Siewert Type III Adenocarcinoma of Esophagogastric JunctionChina
-
John DiazMerck Sharp & Dohme LLC; Florida Department of HealthActive, not recruitingCervical Cancer | Cervical CarcinomaUnited States
-
Jules Bordet InstituteEli Lilly and CompanyCompletedCholangiocarcinoma | Endometrial Cancer | Esophageal Adenocarcinoma | Urothelial/Bladder Cancer, Nos | Esophagus SCCFrance, Belgium
-
Clinical Hospital Centre ZagrebActive, not recruitingNon-muscle-invasive Bladder CancerCroatia
-
Case Comprehensive Cancer CenterActive, not recruitingAdenocarcinoma of the Gastroesophageal Junction | Adenocarcinoma of the Esophagus | Stage IIIA Esophageal Cancer | Stage IIIB Esophageal Cancer | Stage IIIC Esophageal Cancer | Adenocarcinoma of the Gastric CardiaUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedEndometrial Serous Adenocarcinoma | Stage IIIA Uterine Corpus Cancer | Stage IIIB Uterine Corpus Cancer | Stage IVA Uterine Corpus Cancer | Stage IVB Uterine Corpus Cancer | Stage IIIC1 Uterine Corpus Cancer | Stage IIIC2 Uterine Corpus CancerUnited States
-
Michael SimonNational Cancer Institute (NCI)CompletedInvasive Breast Carcinoma | Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7United States
-
Archivel Farma S.L.Fundació Institut Germans Trias i PujolCompletedHigh-Risk Non-Muscle-Invasive Bladder CancerSpain
-
Centre Jean PerrinWithdrawn
-
Guangzhou Medical UniversityCompletedLung Adenocarcinoma | Brain MetastasesChina
-
University of Southern CaliforniaCompletedGastric Cancer | Pancreatic Cancer | Bile Duct Cancer | Duodenum CancerUnited States
-
University Hospital FreiburgNational Cancer Institute (NCI)UnknownGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal CancerGermany
-
University of California, San FranciscoNational Cancer Institute (NCI)WithdrawnGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal CancerUnited States
-
Dokuz Eylul UniversityNot yet recruitingBladder Cancer | Gemcitabine | BCG | Docetaxel | Intravesical InstillationTurkey
-
Ractigen Therapeutics.RecruitingNon-Muscle-Invasive Bladder Cancer (NMIBC)Australia
-
Janssen Research & Development, LLCRecruitingNon-Muscle Invasive Bladder CancerUnited States, Israel
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingHigh-risk Non-muscle Invasive Bladder CancerChina
-
RenJi HospitalNot yet recruitingBiliary Tract Diseases | Intrahepatic Cholangiocarcinoma | Biliary Tract Neoplasms | Gallbladder Cancer | Extrahepatic Bile Duct Cancer | Gall Stone
-
Johns Hopkins UniversityRecruitingNon-Muscle Invasive Bladder CancerUnited States